“I was definitely thrilled to have had those long and lonely
hours of research work recognized on such a platform,” said Andey, a Ghana
native. “I perceive the award to be a validation of the progressive research
environment that FAMU has has been fostering.”
Andey’s research discusses that one of the major challenges with cancer chemotherapy is the growing incidence of relapse. His study targeted a protein AnnexinA2 by inhibiting its expressing at the molecular level in lung cancer cells. His work supports the growing evidence that targets SP cells in tumors, which represents one of the new frontiers in targeted therapy of chemotherapy-resistant cancer.
Andey attributes his success to the consistent research
environment he has been immersed in under FAMU Pharmacy Professor Mandip S.
Sachdeva.
“I appreciate the support of the faculty and staff of the
College of Pharmacy and Pharmaceutical Sciences, as well as Dr. Verian Thomas,
for putting their bet on me,” a humbled Andey said. “I am more than what I
could have hoped to be because of their investments in me.”